Fate Therapeutics (FATE) Q4 2022 Earnings

28FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.89
-0.79
-0.68
-0.58

Details

Expected EPS
-0.86
Actual EPS
-0.58
Surprise EPS
0.28
Surprise Percent
+32.56%

Description

Fate Therapeutics (FATE) has reported earnings of -0.58 per share for Q4 2022.

0 Comments

Share your thoughts